Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Human Stage Holdings (TSE:321A) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Human Stage Holdings's Enterprise Value for the quarter that ended in Mar. 2026 was 円1,001 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Human Stage Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円155 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Stage Holdings EV-to-EBIT Related Terms
Human Stage Holdings EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for Human Stage Holdings's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Stage Holdings EV-to-EBIT Chart
Human Stage Holdings Annual Data
Trend
Mar24
Mar25
Mar26
EV-to-EBIT
0.00
14.17
6.47
Human Stage Holdings Semi-Annual Data
Mar24
Sep24
Mar25
Sep25
Mar26
EV-to-EBIT
0.00
0.00
14.17
0.00
6.47
TSE:321A vs HON, MMM: EV-to-EBIT Comparison
For the Conglomerates subindustry, Human Stage Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Human Stage Holdings EV-to-EBIT vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Human Stage Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Human Stage Holdings's EV-to-EBIT falls into.
Human Stage Holdings's current Enterprise Value is 円707 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Human Stage Holdings's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was 円155 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Human Stage Holdings (TSE:321A) has a EV-to-EBIT of 4.57 as of Aug. 24, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Human Stage Holdings and its competitors. This is 68% below median its historical median of 14.17. Over the past decade, Human Stage Holdings' EV-to-EBIT has ranged from 2.14 to 14.17.
Is Human Stage Holdings' EV-to-EBIT too high?
Human Stage Holdings' current EV-to-EBIT of 4.57 is 68% below median its 10-year median of 14.17. Over the past 10 years, this metric has ranged from a low of 2.14 to a high of 14.17. The Conglomerates industry median EV-to-EBIT is 11.52. Human Stage Holdings' value of 4.57 is 60.3% below this industry median. Overall, Human Stage Holdings has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Human Stage Holdings' EV-to-EBIT compare to HON and MMM?
Human Stage Holdings' EV-to-EBIT of 4.57 can be compared against companies in the Conglomerates industry. The industry median EV-to-EBIT is 11.52. Human Stage Holdings' value of 4.57 is 60.3% below this benchmark. Historically, Human Stage Holdings' own EV-to-EBIT has ranged from 2.14 to 14.17 over the past decade. While the company's 10-year median is 14.17 vs. the industry median of 11.52, Human Stage Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Conglomerates company?
The median EV-to-EBIT among Conglomerates companies is 11.52, based on 451 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Human Stage Holdings's current EV-to-EBIT of 4.57 is 60.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Human Stage Holdings and its competitors. For the Conglomerates industry, the median EV-to-EBIT is 11.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Human Stage Holdings's current EV-to-EBIT is 4.57, which is 68% below median its own 10-year median of 14.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Human Stage Holdings stock overvalued right now?
Human Stage Holdings (TSE:321A) has a current EV-to-EBIT of 4.57. The current EV-to-EBIT is 4.57, which is 68% below median its 10-year median of 14.17 and 60.3% below the Conglomerates industry median of 11.52. Human Stage Holdings' overall GF Score™ is 12/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Human Stage Holdings (TSE:321A), the current EV-to-EBIT is 4.57 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Human Stage Holdings Corp is engaged in consulting services related to asset management and operation of group subsidiaries engaged in the temporary staffing business and real estate leasing business.
12GF Score
Get the complete analysis for TSE:321A
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:321A has been successfully added to your 
